fullerene c60 has been researched along with geldanamycin in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (geldanamycin) | Trials (geldanamycin) | Recent Studies (post-2010) (geldanamycin) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 1,167 | 1 | 329 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimuro, M; Kagawa, H; Mashino, T; Nakamura, S; Ohe, T; Ono, T; Ui, S; Watanabe, H; Watanabe, T; Yagi, S | 1 |
1 other study(ies) available for fullerene c60 and geldanamycin
| Article | Year |
|---|---|
Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Bridged-Ring Compounds; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Drug Screening Assays, Antitumor; Fullerenes; Herpesvirus 8, Human; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Lymphoma, Primary Effusion; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrrolidines; Serine; Virion | 2014 |